[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,935,093
  • Shares Outstanding, K 42,917
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -516 M
  • EBITDA $ -353 M
  • 60-Month Beta 3.15
  • Price/Sales 19.22
  • Price/Cash Flow N/A
  • Price/Book 1.13

Options Overview Details

View History
  • Implied Volatility 83.35% (-0.98%)
  • Historical Volatility 71.73%
  • IV Percentile 18%
  • IV Rank 34.26%
  • IV High 114.54% on 10/30/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 16) 7.65 (11.21%)
  • Put/Call Vol Ratio 0.62
  • Today's Volume 341
  • Volume Avg (30-Day) 736
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 22,348
  • Open Int (30-Day) 24,334
  • Expected Range 60.62 to 75.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-2.91
  • Number of Estimates 2
  • High Estimate $-2.84
  • Low Estimate $-2.98
  • Prior Year $-3.18
  • Growth Rate Est. (year over year) +8.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.52 +25.22%
on 06/01/26
69.63 -1.95%
on 06/30/26
-3.41 (-4.76%)
since 05/29/26
3-Month
44.06 +54.95%
on 04/10/26
79.50 -14.13%
on 05/28/26
+21.37 (+45.57%)
since 03/30/26
52-Week
29.95 +127.95%
on 08/20/25
118.84 -42.55%
on 01/22/26
+16.85 (+32.77%)
since 06/30/25

Most Recent Stories

More News
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , June 30, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

GRAL : 68.27 (-0.18%)
$GRAL Notification: GRAIL, Inc. Accused of Misrepresentations about its Trial Results in Securities Fraud Class Action

A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer...

GRAL : 68.27 (-0.18%)
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

SAN FRANCISCO , June 29, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. ( NASDAQ: GRAL ) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri...

GRAL : 68.27 (-0.18%)
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

NEW YORK , June 28, 2026 /PRNewswire/ --

GRAL : 68.27 (-0.18%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL

NEW YORK , June 25, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL). Such investors are advised...

GRAL : 68.27 (-0.18%)
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS

SAN FRANCISCO , June 25, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. ( NASDAQ: GRAL ) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri...

GRAL : 68.27 (-0.18%)
GRAIL Completes $110 Million Equity Financing With Samsung Entities

MENLO PARK, Calif. , June 25, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the closing of its...

GRAL : 68.27 (-0.18%)
GRAL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO , June 25, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Grail class action lawsuit seeks to represent purchasers or acquirers of GRAIL, Inc....

GRAL : 68.27 (-0.18%)
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , June 24, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

GRAL : 68.27 (-0.18%)
Lost Money on Grail, Inc. (GRAL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

From Optimism to Disillusionment: How Investor Sentiment in Grail Shifted as NHS-Galleri Confidence Crumbled, Costing Shareholders $51.32 Per Share

GRAL : 68.27 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 73.63
2nd Resistance Point 71.63
1st Resistance Point 69.95
Last Price 68.27
1st Support Level 66.27
2nd Support Level 64.27
3rd Support Level 62.59

See More

52-Week High 118.84
Fibonacci 61.8% 84.88
Fibonacci 50% 74.39
Last Price 68.27
Fibonacci 38.2% 63.91
52-Week Low 29.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.